UBS AM
GRTS

UBS AM’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

UBS AM’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-350,465
Closed -$2.33M – 2513
2020
Q2 		$2.33M Buy
350,465
+14,062
+4% +$94.7K ﹤0.01% 1453
2020
Q1 		$1.96M Sell
336,403
-51,338
-13% -$431K ﹤0.01% 1417
2019
Q4 		$3.48M Sell
387,741
-2,818
-0.7% -$23.5K ﹤0.01% 1347
2019
Q3 		$3.37M Sell
390,559
-12,698
-3% -$128K ﹤0.01% 1370
2019
Q2 		$4.49M Buy
403,257
+128,062
+47% +$1.46M ﹤0.01% 1239
2019
Q1 		$3.66M Buy
275,195
+59,619
+28% +$797K ﹤0.01% 1263
2018
Q4 		$3.33M Buy
+215,576
New +$4.11M ﹤0.01% 1232

Other funds holding GRTS

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM's GRTS Position: Q3 2020 in Review

UBS AM sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2020, closing a stake of 350,465 shares — an estimated $2.33M sold.

UBS AM first reported a position in GRTS in Q4 2018 and held it in 7 quarters. The position peaked at $4.49M in Q2 2019. 69 funds tracked by Wall St. Rank hold GRTS as of Q3 2020.

  • UBS AM reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • UBS AM sold 350,465 Gritstone bio, Inc. Common Stock shares in Q3 2020, an estimated $2.33M.
  • UBS AM first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 7 quarters.
  • UBS AM's Gritstone bio, Inc. Common Stock position peaked at $4.49M in Q2 2019.
  • 69 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2020.

Based on UBS AM's 13F filing for Q3 2020, filed 13 Nov 2020.